Literature DB >> 7091479

Characteristics of patients referred for treatment of end-stage renal disease in a defined population.

R A Hiatt, G D Friedman.   

Abstract

We studied the incidence of referral for treatment of end-stage renal disease (ESRD) in the Kaiser Foundation Health Plan (KFHP) in northern California from 1972 through 1977. In this population of over 1 million persons, we found an age-adjusted annual incidence of 44.9 per million after 1973, when the Federal ESRD Program went into effect. Age-specific incidence was highest in in men greater than 70 years of age and in women in the 50- to 59-year age group; the male/female ratio was 1.4:1. The most common diagnoses of patients referred with ESRD were glomerulonephritis (11.4 per million per year), diabetic nephropathy (5.0 per million per year), primary hypertensive disease (3.1 per million per year), and polycystic kidney disease (2.4 per million per year). Estimated rates of referral for ESRD were highest for Blacks, lowest for Whites, and intermediate for Asians. Incidence varied by geographic area within the health plan service area and was highest where the percentage of the Black population was highest.

Entities:  

Mesh:

Year:  1982        PMID: 7091479      PMCID: PMC1650351          DOI: 10.2105/ajph.72.8.829

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  7 in total

1.  Relevance of medical research to patient care.

Authors:  N B Cummings
Journal:  Trans Stud Coll Physicians Phila       Date:  1976-10

2.  An areawide survey of treated end-stage renal disease.

Authors:  J S Mausner; J K Clark; B I Coles; H Menduke
Journal:  Am J Public Health       Date:  1978-02       Impact factor: 9.308

3.  A regional end-stage renal disease program: twelve years' experience.

Authors:  R V Cestero; M O Jacobs; R B Freeman
Journal:  Ann Intern Med       Date:  1980-09       Impact factor: 25.391

4.  Treatment of end-stage renal disease.

Authors: 
Journal:  N Engl J Med       Date:  1981-02-05       Impact factor: 91.245

5.  Treatment of end-stage renal disease: free but not equal.

Authors:  A S Relman; D Rennie
Journal:  N Engl J Med       Date:  1980-10-23       Impact factor: 91.245

6.  Racial factors in the incidence and causation of end-stage renal disease (ESRD).

Authors:  R E Easterling
Journal:  Trans Am Soc Artif Intern Organs       Date:  1977

7.  Characteristics of Connecticut patients receiving services for end-stage uremia.

Authors:  D A Pearson; T J Stranova; J D Thompson
Journal:  Public Health Rep       Date:  1975 Sep-Oct       Impact factor: 2.792

  7 in total
  24 in total

1.  The need and demand for renal replacement therapy in ethnic minorities in England.

Authors:  P J Roderick; V S Raleigh; L Hallam; N P Mallick
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

2.  Cohort Profile: The Diabetes Study of Northern California (DISTANCE)--objectives and design of a survey follow-up study of social health disparities in a managed care population.

Authors:  Howard H Moffet; Nancy Adler; Dean Schillinger; Ameena T Ahmed; Barbara Laraia; Joe V Selby; Romain Neugebauer; Jennifer Y Liu; Melissa M Parker; Margaret Warton; Andrew J Karter
Journal:  Int J Epidemiol       Date:  2008-03-07       Impact factor: 7.196

3.  Longitudinal study of new and prevalent use of self-monitoring of blood glucose.

Authors:  Andrew J Karter; Melissa M Parker; Howard H Moffet; Michele M Spence; James Chan; Susan L Ettner; Joe V Selby
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

4.  An algorithm to identify medication nonpersistence using electronic pharmacy databases.

Authors:  Melissa M Parker; Howard H Moffet; Alyce Adams; Andrew J Karter
Journal:  J Am Med Inform Assoc       Date:  2015-06-15       Impact factor: 4.497

5.  Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California Diabetes Registry.

Authors:  Andrew J Karter; Howard H Moffet; Jennifer Liu; Melissa M Parker; Ameena T Ahmed; Assiamira Ferrara; Joe V Selby
Journal:  Am J Manag Care       Date:  2005-04       Impact factor: 2.229

6.  Negative selection of patients for dialysis and transplantation in the United Kingdom.

Authors:  S Challah; A J Wing; R Bauer; R W Morris; S A Schroeder
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

7.  Glycemic response to newly initiated diabetes therapies.

Authors:  Andrew J Karter; Howard H Moffet; Jennifer Liu; Melissa M Parker; Ameena T Ahmed; Alan S Go; Joe V Selby
Journal:  Am J Manag Care       Date:  2007-11       Impact factor: 2.229

8.  Smoking habits among multiphasic examinees, 1979 to 1984.

Authors:  G D Friedman; S Sidney; M R Polen
Journal:  West J Med       Date:  1986-11

9.  Epidemiologic features of treated end-stage renal disease in a large prepaid health plan.

Authors:  J D Ordonez; R A Hiatt; C P Quesenberry
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

10.  Health care use by frequent marijuana smokers who do not smoke tobacco.

Authors:  M R Polen; S Sidney; I S Tekawa; M Sadler; G D Friedman
Journal:  West J Med       Date:  1993-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.